Honorary graduates
The University’s honorary graduates are highly distinguished leaders, recognised for their scholarship, professional distinction, outstanding community service or contribution to the arts, industry or business. Such recognition, conferred by the University Council, is one of the highest honours the University can award an individual.
The recipients of honorary awards (honoris causa) have made outstanding contributions in their respective fields and communities. A full roll of Monash honorary graduates is available through Monash records and archives. Our faculty is proud to be closely associated with the following recipients:
| Valentino John Stella |
| Geoffrey Norman Vaughan AO |
| Ho-Leung Fung |
| Paul Michel Georges Remi Vanhoutte |
| Kamal K Midha |
| Professor Brian Kobilka MD |
![]() | Dr Ian Wilding |
| Professor Robert A Blouin Bob Blouin, Dean of Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Doctor of Laws Honoris causa on 25 May 2017 for his contributions to education and research. |
| Emeritus Professor Jean-Pierre Changeux |
| Dr John Howard McCall MacBain and Dr Marcy McCall MacBain Since its formation in Geneva, Switzerland in 2007, the McCall MacBain Foundation has committed over $200 million of charitable donations for scholarships and education, health and the environment in Canada, Europe, sub-Saharan Africa, Australia and New Zealand. |
| Alistair Lloyd was awarded an Honorary Doctorate (Doctor of Laws; honoris causa), on 14 October 2022 for his many outstanding and valuable contributions to the pharmacy profession as a community pharmacist and in various senior leadership roles with the Pharmaceutical Society of Victoria and the profession. |
| Jennifer Martin was awarded an Honorary Doctorate (Doctor of Laws; honoris causa) on 28 April 2026 for her pioneering discoveries that have transformed our understanding of protein function, redox biology and bacterial virulence. Her work reveals the three-dimensional structures of proteins, a foundation of modern drug design. |





